Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

US startups raise over $50 billion VC funding during Jan-May 2024 despite decline in deal volume, reveals GlobalData

The US startups secured $52.6 billion venture capital (VC) funding through 1,985 deals in the first five months of 2024. Despite a significant year-on-year (YoY) decline in deal volume, the funding value dropped only slightly, highlighting a trend of larger investments in fewer deals. Notably, May saw a surge with four billion-dollar deals, emphasizing cautious […]
Read more

Beacon Therapeutics’ AGTC-501 holds potential to become first gene therapy in XLRP space, says GlobalData

Beacon Therapeutics initiated the final leg of the race for its lead asset, AGTC-501 (laruparetigene zovaparvovec), announcing recently that the company has treated its first patient in the pivotal trial, VISTA. Currently, the only retinitis pigmentosa therapy on the market is Spark Therapeutics’ Luxturna (voretigene neparvovec), a retinoid isomerohydrolase activator, indicated for patients with confirmed […]
Read more

Companies seen hiring for industrial metaverse roles, finds GlobalData

As the concept of an industrial metaverse unfolds, businesses are navigating the digital landscape, adapting, innovating, and using digital twins to improve efficiency. Against this backdrop, companies are actively hiring for roles that leverage artificial intelligence (AI), augmented reality (AR), virtual reality (VR), and other advanced technologies to optimize operations and stay competitive in the […]
Read more

Global transformers market to reach $51.33 billion in 2028, led by the Asia-Pacific region, forecasts GlobalData

The global power industry is witnessing significant growth, with the global power transformers market projected to reach $23.60 billion, and the distribution transformers market expected to hit $27.73 billion by 2028. In 2023, the Asia-Pacific (APAC) region emerged as the market leader, fueled by heightened commercial activity in Southeast Asia and substantial asset demands in […]
Read more

Global travel and tourism deals drop 10.9%; PE deals and European markets shine during January-May 2024, reveals GlobalData

Travel and tourism sector witnessed 10.9% year-on-year (YoY) decline in the number of deals (mergers and acquisitions (M&A), private equity (PE) and venture financing) announced globally during January-May 2024. Despite this downturn, PE deals showed improvement, and European markets showed growth, highlighting new opportunities for strategic investments, according to GlobalData, a leading data and analytics […]
Read more

Industrial metaverse gains prominence in companies discussions and filing documents, finds GlobalData

The industrial metaverse has been gaining prominence among businesses and the growing interest is evident from discussions by companies in filing documents. Companies across various industries are exploring its potential to optimize business processes, enhance efficiency, lower costs, and promote sustainability. Notable collaborations, like those between Siemens and NVIDIA, highlight the industrial metaverse’s growing impact […]
Read more

US inflation drop to 3.3% ignites influencers discussion on potential Fed rate cuts, reveals GlobalData

The US inflation, as measured by the Consumer Price Index (CPI), declined to 3.3% in May from 3.4% in April, becoming a trending topic among influencers on the social media platform “X.” This lower-than-expected inflation reading has sparked significant debate regarding its implications for future US monetary policy. Many consider it a key indicator that […]
Read more

Tapinarof may mark Dermavant’s first atopic dermatitis approval, says GlobalData

Dermavant’s VTAMA (tapinarof), a nonsteroidal, topical AhR-modulating agent, achieved positive Phase III trial results in atopic dermatitis patients aged two and above, leading to FDA acceptance of its supplemental new drug application (sNDA). The promising results may bring Dermavant’s VTAMA closer to market authorization and will be its first atopic dermatitis marketed drug, subject to […]
Read more
1 … 131 132 133 134 135 … 776